TrialThe Canadian journal of cardiology2013

Targeted ablation at stable atrial fibrillation sources improves success over conventional ablation in high-risk patients: a substudy of the CONFIRM Trial.

Tina Baykaner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.